Comparison of Medications for Heart Failure Finds Difference in Risk of Death

ScienceDaily (2011-01-13) -- In a comparison of the angiotensin II receptor blockers candesartan and losartan, used by patients with heart failure, candesartan was associated with a lower risk of death at 1 and 5 years, according to a new study.

RA in Men Associated With Mortality Risk

By Nancy Walsh, Staff Writer, MedPage Today

Men with rheumatoid arthritis were more than twice as likely to die over a seven-year period as their counterparts in the general population, researchers found.
Full Article